Synthesis, Crystal Structures and Binding Studies of Flufenamic‐ Acid‐Based Metal Complexes

[1]  V. Zeleňák,et al.  Synthesis, characterization, DNA binding, topoisomerase I inhibition and antimicrobial activity of four novel zinc(II) fenamates , 2018 .

[2]  V. Zeleňák,et al.  Novel Zn(II) complexes with non-steroidal anti-inflammatory ligand, flufenamic acid: Characterization, topoisomerase I inhibition activity, DNA and HSA binding studies. , 2017, Journal of inorganic biochemistry.

[3]  V. Psycharis,et al.  Zinc complexes of flufenamic acid: Characterization and biological evaluation. , 2016, Journal of inorganic biochemistry.

[4]  I. Turel,et al.  Cobalt(II) complexes with non-steroidal anti-inflammatory drugs and α-diimines. , 2016, Journal of inorganic biochemistry.

[5]  I. Bruno,et al.  Cambridge Structural Database , 2002 .

[6]  P. Chowdhury,et al.  Unusual domain movement in a multidomain protein in the presence of macromolecular crowders. , 2015, Physical chemistry chemical physics : PCCP.

[7]  C. Fu,et al.  Synthesis, crystal structures, and properties of three metal complexes with N-phenylanthranilic acid , 2015 .

[8]  G. Perlovich,et al.  Fenamate Cocrystals with 4,4′-Bipyridine: Structural and Thermodynamic Aspects , 2015 .

[9]  B. Chromy,et al.  High abundant protein removal from rodent blood for biomarker discovery. , 2014, Biochemical and biophysical research communications.

[10]  Hui Liu,et al.  Manganese-mefenamic acid complexes exhibit high lipoxygenase inhibitory activity. , 2014, Dalton transactions.

[11]  Da-qi Wang,et al.  Construction of six non-covalent-bonded supramolecules from reactions of cadmium(II), and zinc(II) with 3,5-dimethylpyrazole and carboxylate ligands , 2014 .

[12]  I. Turel,et al.  Manganese(II) complexes with the non-steroidal anti-inflammatory drug tolfenamic acid: structure and biological perspectives. , 2014, Inorganic chemistry.

[13]  I. Turel,et al.  Antioxidant capacity and DNA-interaction studies of zinc complexes with a non-steroidal anti-inflammatory drug, mefenamic acid. , 2013, Journal of inorganic biochemistry.

[14]  R. Ambrus,et al.  Nanonization of Niflumic Acid by Co-Grinding , 2013 .

[15]  Norbert Radacsi,et al.  Microwave-Assisted Evaporative Crystallization of Niflumic Acid for Particle Size Reduction , 2013 .

[16]  C. Garino,et al.  Copper(II) interacting with the non-steroidal antiinflammatory drug flufenamic acid: structure, antioxidant activity and binding to DNA and albumins. , 2013, Journal of inorganic biochemistry.

[17]  J. H. T. Horst,et al.  Atmospheric pressure cold plasma synthesis of submicrometer-sized pharmaceuticals with improved physicochemical properties , 2012 .

[18]  V. Psycharis,et al.  Structural features of mono- and tri-nuclear Zn(II) complexes with a non-steroidal anti-inflammatory drug as ligand. , 2012, Dalton transactions.

[19]  I. Turel,et al.  Cobalt(II) complexes with non-steroidal anti-inflammatory drug tolfenamic acid: Structure and biological evaluation. , 2012, European journal of medicinal chemistry.

[20]  Sema Çağlar,et al.  Synthesis, Characterization, and Crystal Structures of a Novel [Zn3(bba)6(3-pic)2] Complex (bba = 2-Benzoylbenzoat, 3-pic = 3-Picoline) , 2011 .

[21]  A. Castiñeiras,et al.  Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity. , 2011, Journal of inorganic biochemistry.

[22]  A. Terzis,et al.  Non-steroidal antiinflammatory drug-copper(II) complexes: structure and biological perspectives. , 2011, Dalton transactions.

[23]  Kevin S. Eccles,et al.  Cocrystals of fenamic acids with nicotinamide , 2011 .

[24]  Umesh Kumar,et al.  Effects of steric/basic properties of Lewis bases on the degree of aggregation of zinc(II) pivalate complexes , 2011 .

[25]  G. Baranauskas,et al.  Flufenamic acid decreases neuronal excitability through modulation of voltage‐gated sodium channel gating , 2010, The Journal of physiology.

[26]  V. Psycharis,et al.  Biological evaluation of non-steroidal anti-inflammatory drugs-cobalt(II) complexes. , 2010, Dalton transactions.

[27]  Horacio López-Sandoval,et al.  Synthesis, structure and biological activities of cobalt(II) and zinc(II) coordination compounds with 2-benzimidazole derivatives. , 2008, Journal of inorganic biochemistry.

[28]  M. Spackman,et al.  Comparison of Polymorphic Molecular Crystal Structures through Hirshfeld Surface Analysis , 2007 .

[29]  Zhenxia Chen,et al.  Crystal engineering of zinc(II) and copper(II) complexes containing 3,5-dimethylisoxazole-4-carboxylate ligand via O–H⋯N, C–H⋯A (A = N, O and π) and bifurcated C–H⋯N/O interactions , 2007 .

[30]  Yong-mei Wang,et al.  Synthesis, structure and biological activity of cobalt(II) and copper(II) complexes of valine-derived schiff bases. , 2006, Journal of inorganic biochemistry.

[31]  H. Kozłowski,et al.  Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt(III) complex. , 2006, Journal of inorganic biochemistry.

[32]  Yang Wen,et al.  N-Benzoyl-N'-dialkylthiourea derivatives and their Co(III) complexes: structure, and antifungal. , 2005, Journal of inorganic biochemistry.

[33]  S. Baek,et al.  Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene. , 2004, Biochemical and biophysical research communications.

[34]  I. Han,et al.  Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathway. , 2004, Life sciences.

[35]  Jan-Marino Ramirez,et al.  Differential Contribution of Pacemaker Properties to the Generation of Respiratory Rhythms during Normoxia and Hypoxia , 2004, Neuron.

[36]  N. C. Kasuga,et al.  Synthesis and structural characterization of silver(I), aluminium(III) and cobalt(II) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver(I)-oxygen bonding complexes on the antimicrobial activities. , 2004, Journal of inorganic biochemistry.

[37]  M. Hull,et al.  The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. , 2000, European journal of cancer.

[38]  H. Gray,et al.  Inhibition of thermolysin and human α-thrombin by cobalt(III) Schiff base complexes , 1999 .

[39]  M. Clynes,et al.  Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). , 1998, European journal of cancer.

[40]  H. Gray,et al.  Spectroscopy and Electrochemistry of Cobalt(III) Schiff Base Complexes , 1997 .

[41]  P. Vyas,et al.  The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Cook,et al.  Intracellular Ca2+ release by flufenamic acid and other blockers of the non‐selective cation channel , 1992, FEBS letters.

[43]  M. Hursthouse,et al.  Preparation, X-ray crystal structure, and magnetic properties of a trinuclear cobalt(II) carboxylate , 1975 .